Guidance for Treating Patients with Opioid Use Disorder (OUD) with Buprenorphine- Naloxone (B/N) in the COVID-19 Era via Telehealth: A Review of Previous Evidence, New COVID-19 OUD Treatment Guidelines, and a Case Report of their Application
dc.contributor.author | Sokol, Randi | |
dc.contributor.author | Gupta, Ankit | |
dc.contributor.author | Powers, Sarah | |
dc.contributor.author | Hoffman, Liza | |
dc.contributor.author | Meza, Julio | |
dc.date.accessioned | 2020-06-08T15:59:42Z | |
dc.date.available | 2020-06-08T15:59:42Z | |
dc.date.issued | 2020-06-08 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/155566 | |
dc.description.abstract | Background: During the COVID-19 pandemic, frontline primary care providers care face the challenge of providing access to the evidence-based medication for the treatment of opioid use disorder (OUD). Telehealth has emerged as an approach to enhance access to treatment with buprenorphine-naloxone (B/N) to support patients' recovery while keeping them and their providers safe. Lessons learned: In this case report of a telehealth company's response to the pandemic, we share lessons learned in treating patients with OUD during the COVID-19 pandemic that consider the evidence base, new COVID-19 related guidelines and their application. Conclusion: Understanding the evidence and current COVID-19-related guidelines can help frontline primary care providers employ new approaches to support patients with OUD by providing B/N in a safe way that minimizes COVID-19 exposure risk and maximizes recovery support. | en_US |
dc.language.iso | en_US | en_US |
dc.relation.ispartofseries | Annals of Family Medicine, COVID-19 Collection | en_US |
dc.subject | buprenorphine-naloxone (B/N), opioid use disorder (OUD), telehealth, telemedicine, COVID-19 pandemic | en_US |
dc.title | Guidance for Treating Patients with Opioid Use Disorder (OUD) with Buprenorphine- Naloxone (B/N) in the COVID-19 Era via Telehealth: A Review of Previous Evidence, New COVID-19 OUD Treatment Guidelines, and a Case Report of their Application | en_US |
dc.type | Preprint | en_US |
dc.subject.hlbsecondlevel | Epidemiology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.contributor.affiliationum | Annals of Family Medicine, Department of Family Medicine, University of Michigan Medical School | en_US |
dc.contributor.affiliationother | Cambridge Health Alliance | en_US |
dc.contributor.affiliationother | Bicycle Health | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/155566/1/Sokol article file.pdf | |
dc.owningcollname | COVID-19: Annals of Family Medicine |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.